| Document |
Document Title |
|
WO/2015/020253A1 |
The present invention comprises: a first step of aging soybeans for a predetermined period of time to prepare cheonggukjang, and preparing onions dried in the sun and roasted peanuts; a second step of drying the cheonggukjang in the sun,...
|
|
WO/2015/020191A1 |
Provided is a calcium agent that is easily ingested and has superior flavor, disintegration properties in the mouth, and the like. The calcium agent has superior flavor, disintegration properties in the mouth, and the like by means of ad...
|
|
WO/2015/021060A1 |
A palatable, single serving dietary supplement of amino acids that may be taken as a nutritional aid to improve health and well-being by promoting higher quality sleep, enhancing repair of muscular tissue after strenuous exercise in part...
|
|
WO/2015/020138A1 |
The purpose of the present invention is to provide a means for promoting the in vivo absorption of hydroxytyrosol or a derivative thereof, prolonging the in vivo residence time, and sustaining the effect. As a result of in-depth studies,...
|
|
WO/2015/017934A1 |
Described herein is the use of resistant potato starch as an effective dietary supplement offering protection against multiple metabolic risk factors that are associated with cardiovascular disease and diabetes, including High Density Li...
|
|
WO/2015/018631A1 |
The invention relates to a composition that provides enhanced macro/ microcirculation when applied on skin or is ingested. This composition has applications in areas such as reduction of under-eye dark circles, scalp health, reduction in...
|
|
WO/2015/020186A1 |
By means of a tablet composition containing lactoferrin having an average particle size of 40-300 μm, provided is a tablet composition that contains lactoferrin, has a low friability, and has superior lactoferrin leachability and tablet...
|
|
WO/2015/016682A1 |
Provided are a pharmaceutical composition for preventing or treating diabetes mellitus, containing geraniol or a pharmaceutically acceptable salt thereof as an active ingredient, a method for preventing or treating an individual with dia...
|
|
WO/2015/016826A1 |
Dietary particle compositions for ruminant feed are disclosed, as well as methods for their preparation and use. The compositions may include a fatty acid compound, a core, and at least one encapsulating agent. The dietary particle may h...
|
|
WO/2015/014497A1 |
The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at...
|
|
WO/2015/016823A1 |
Dietary paste compositions for ruminants are disclosed, as well as methods for their preparation and use. The dietary paste compositions may include least one saturated fatty acid compound and at least one carrier component. The methods ...
|
|
WO/2015/016820A1 |
Mineral lick compositions for ruminants are disclosed, as well as methods for their preparation and use. The compositions may include at least one sodium salt, at least one calcium salt, at least one magnesium salt, and at least one fatt...
|
|
WO/2015/017073A1 |
A composition and method for enhancing brain development in a pediatric subject, the method including administering to the pediatric subject a nutritional composition having up to about 7 g/100 kcal of a fat or lipid source, wherein the ...
|
|
WO/2015/016830A1 |
A feed for ruminants may include at least one derivatized fatty acid component such that ingestion of the feed by lactating ruminants may provide for an increase in the amount of milk produced by the ruminant, and/or an increase in the f...
|
|
WO/2015/016285A1 |
Provided is a brain function-improving composition which can inhibit binding of homocysteic acid to a receptor (NMDA receptor) and, at the same time, decrease the binding ability of homocysteic acid per se to the receptor to thereby impr...
|
|
WO/2015/015815A1 |
The present invention addresses the issue of providing a fibroblast activator being highly safe and capable of being used as a pharmaceutical, a quasi-drug, an external skin preparation, a cosmetic, a food or drink, a food additive, or f...
|
|
WO/2015/015816A1 |
The present invention addresses the issue of providing a fibroblast activator being highly safe and capable of being used as a pharmaceutical, a quasi-drug, an external skin preparation, a cosmetic, a food or drink, a food additive, or f...
|
|
WO/2015/013932A1 |
A nutritional composition for inhibiting growth of tumor comprising : a milk protein hydrolysate and a fermented milk protein as proteins; a oleic acid-containing oil and milk phospholipid and/or soybean lecithin as lipids; and isomaltul...
|
|
WO/2015/014967A1 |
A composition for use in developing and/or improving brain function comprises a glyceride having a palmitoyl group at the 2- position wherein at least 40% by weight of the palmitic acid content of the composition is present as palmitoyl ...
|
|
WO/2015/017411A1 |
A method of manufacturing an edible article, namely a fried product such as popcorn infused with various flavorings, and more particularly, to methods of making fried products infused with various flavorings.
|
|
WO/2015/015149A1 |
The present invention relates to a dietary supplement comprising a blend of essential amino acids (EEAs) which is rich in leucine and its use in combatting the degenerative loss of muscle characteristics which typify sarcopenia.
|
|
WO/2015/016819A1 |
Liquid dietary compositions for ruminants are disclosed, as well as methods for their preparation and use. The compositions may include a fatty acid component, at least one feed ingredient, and water. The fatty acid component may include...
|
|
WO/2015/017625A1 |
A functional food composition comprising an edible or potable substance, a cross-linked edible matrix encapsulating the edible or potable substance, a probiotic, and a prebiotic, with the proviso that the edible or potable substance and ...
|
|
WO/2015/011307A1 |
The invention relates to a natural product comprising a mixture of fish oil and/or algae oil and virgin vegetable oils, for use in the preparation of sea-derived food products, for: creating a gastronomically satisfying oil with a pleasa...
|
|
WO/2015/013678A2 |
A composition comprising a medium chain fatty acid (MCFA), at least one polyunsaturated fatty acid (PUFA), and at least one protein, is provided. The composition improves or preserves the stability of polyunsaturated fatty acids (PUFAs)....
|
|
WO/2015/010228A1 |
Disclosed is an improvement in a production technology and an evaluation system for starch noodles. On the existing basis, the noodle processing technology is optimized, and the optimization and upgrading of processing devices are enhanc...
|
|
WO/2015/012987A1 |
A partial melt co-crystallization composition containing sugar alcohols such as erythritol and an active; a method of making the partial melt co-crystallization composition; and a method of using the partial melt co-crystallization compo...
|
|
WO/2015/009181A1 |
A food microemulsion constituting a carrier for fish oil and being an intermediate product intended to be introduced into foodstuff to increase the nutritional value of foodstuff is disclosed.
|
|
WO/2015/007997A1 |
The present invention concerns an optimised method for breaking the cell walls of microalgae of the Chlorella genus, more particularly Chlorella vulgaris, Chlorella sorokiniana or Chlorella protothecoides on an industrial scale, implemen...
|
|
WO/2015/008139A1 |
Provided are food, dietary supplements and/or drug compositions having prebiotic effect and their use in human and animal care.
|
|
WO/2015/007748A1 |
The present invention relates to a recombinant microorganism comprising nucleotide sequence(s) encoding: a polypeptide having ent-copalyl pyrophosphate synthase activity; a polypeptide having ent-Kaurene synthase activity; a polypeptide ...
|
|
WO/2015/009407A1 |
The present disclosure relates to methods for promoting neuronal health and/or development in a subject by providing nutritional compositions comprising docosahexaenoic acid and alpha-lipoic acid. The nutritional composition may further ...
|
|
WO/2015/008748A1 |
The present invention provides a botanical soft capsule coating obtaining exceptional coating performance and presenting excellent adhesiveness while having high coating sheet strength, and a soft capsule. A soft capsule coating characte...
|
|
WO/2015/008849A1 |
A self-emulsifying composition which comprises, when taking the total amount of the composition as 100mass%, 70 to 90mass% of at least one compound selected from the group consisting of ω-3 polyunsaturated fatty acids, pharmaceutically ...
|
|
WO/2015/009406A1 |
The present disclosure relates to methods for promoting neuronal health and/or development in a subject by providing nutritional compositions comprising a neurologic component, wherein the neurologic component may promote brain and nervo...
|
|
WO/2015/009225A1 |
The invention concerns a food composition product for weight loss and diabetes management, the food composition product comprising at least two different proteins deriving from both animal and vegetable sources, furthermore Omega 3 and 6...
|
|
WO/2015/004255A1 |
The present invention relates to a novel process for the isolation of unique anti-oxidative glycoproteins from the pH precipitated fractions of enzymatic extracts of brown algae. Two brown seaweeds viz, Fucus serratus and Fucus vesiculos...
|
|
WO/2015/004949A1 |
A Lactobacillus paracasei MCC 1849 (NITE BP-01633) strain having high IL-12-production-promoting effects is used as a component of a medicine, food, beverage, or feed to be used for promoting IL-12 production, immunostimulation, antivira...
|
|
WO/2015/004266A1 |
The present invention relates to a genomic method for producing a personalized nutrient composition for one individual, wherein the nutrient composition is optimized for the individual's genomic risk profile for having or developing one ...
|
|
WO/2015/005393A1 |
The purpose of the present invention is to provide a novel prophylactic or therapeutic agent for aortic aneurysm whereby aortic aneurysm can be prevented and/or treated, and a packaged food or drink comprising the same. As the results of...
|
|
WO/2015/004095A1 |
An active-containing microparticle adapted to release the active in a desired end-use, comprising • (a) an active-containing core active-containing core, optionally formed on an inner core, comprising a continuous hydrophilic medium in...
|
|
WO/2015/005443A1 |
The purpose of the present invention is to provide an oral composition capable of actualizing a brain function-improving function and various other physiological functions. Specifically, the present invention provides an oral composition...
|
|
WO/2015/005301A1 |
The purpose of the present invention is to provide a material from which stabilized PGF2α can be easily obtained and which is not only useful for medical purposes but also easily and commonly applicable to fish culture feeds, livestock ...
|
|
WO/2015/005378A1 |
Provided is a yeast extract and yeast having a high Abu, γ-Glu-Abu, and/or γ-Glu-Abu-Gly content. By means of modifying yeast in a manner so as to decrease the acetolactate synthase activity in the cell, a yeast is obtained having a hi...
|
|
WO/2015/004275A1 |
The present invention relates to a color composition, which is an aqueous composition comprising a source of carmine pigment and a source of ferrous (Fe2+) ions. Also, the present invention relates to the use of the above compositions as...
|
|
WO/2015/005060A1 |
Provided is a method for producing an ellagic acid composition which has excellent solubility in water. A method for producing an ellagic acid composition, which comprises: a step wherein a heat treatment starting material is prepared by...
|
|
WO/2015/004628A1 |
The present disclosure relates to aqueous compositions for coating food products such as French fries, comprising a hydroxypropylated, cross-linked tapioca starch which is a hydroxypropyl di-starch phosphate, and an acetylated, high amyl...
|
|
WO/2015/005466A1 |
A lipid-producing microorganism capable of efficiently producing EPA is provided. A mutant microorganism obtained by introducing a foreign ∆15 desaturase gene, or a foreign ∆12 desaturase gene and one or both of a foreign ∆15 desat...
|
|
WO/2015/002151A1 |
Provided is a method for stabilizing DHNA or a vitamin contained in a food, a beverage and or like under an environment which can be subjected to natural light or artificial light, e.g., a transparent container, without requiring the use...
|
|
WO/2015/000694A1 |
The present invention relates to complexes of lactoferrin, osteopontin and iron. In particular the invention relates to a composition comprising at least 2 g/kg of lactoferrin-osteopontin-iron complex for use in the treatment or preventi...
|
